{"disease":{"id":"recurrent-pterygium-of-eye","name":"recurrent pterygium of eye"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04075227","title":"Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent Pterygium","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Wannisa Suphachearabhan","has_results":false},{"nct_id":"NCT04419038","title":"Evaluation of Conjunctival Autografting With MMC Application Versus Ologen Implantation of Recurrent Pterygium","phase":"NA","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Menoufia University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}